---
schema_version: "secwatch.filing_event.v1"
accession: "0001420720-22-000094"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2022-12-08T23:59:59+00:00"
generated_at: "2026-06-21T07:25:57.402843+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# iBio prices $3.5M underwritten public offering of common stock and warrants

## Summary
- Offering includes 3,365,385 shares (or pre-funded warrants) and Series A/B warrants with $1.04 exercise price.
- Net proceeds to the company are approximately $2.9 million, used for operating costs, R&D, working capital, and debt payments.
- Closing expected on or about December 9, 2022, subject to customary conditions. H.C. Wainwright is sole book-runner.
- Underwriter granted 30-day option to purchase up to an additional 504,807 shares and/or warrants.
- Representative’s Warrants issued to purchase 6% of offering shares at $1.30 exercise price, 5-year term.

## SEC filing metadata
- accession: 0001420720-22-000094
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2022-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000142072022000094/0001420720-22-000094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000142072022000094/ibio-20221206x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001420720-22-000094
- JSON: https://secwatch.observer/filing/0001420720-22-000094.json
- Plain text: https://secwatch.observer/filing/0001420720-22-000094.txt

## Key facts
- Material Agreements
  iBio, Inc. entered into Underwriting Agreement with H.C. Wainwright & Co., LLC valued at approximately $2.9 million (effective 2022-12-06).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: H.C. Wainwright & Co., LLC
  - Value: approximately $2.9 million
  - Effective: 2022-12-06
  source text: On December 6, 2022, iBio, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000142072022000094/0001420720-22-000094-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.